Proteome Sciences Share Discussion Threads

[elpirata] 15/7/2024 09:40

elpirata 15 Jul '24 - 09:39 - 2179 of 2179 Edit
0 0 0
I note DJT Nasdaq (Trump) is already up 60% pre market, Im going to ask peverill if he could arrange to wing CJP

[peverill] 10/7/2024 07:28

How's the takeover coming along wasjobber??

[monte1] 01/7/2024 15:03

If only we could see a bit of revenue or share price creep eh?

[colinhy] 01/7/2024 15:00

In new Alzheimer’s criteria, some see progress while others fear profit-driven ‘diagnostic creep’

By Brenda Goodman, CNN Mon July 1, 2024

[wasjobber] 29/6/2024 10:41

pools2

Proteome Sciences did say in their recent 2023 annual report that they had critical intellectual property for Alzheimer's disease and cancer. The information you've provided is an important part of the regulatory AD framework and, as you suggest, very important for Proteome Sciences shareholders. Well done and many thanks.


STRONG BUY

[pools2] 29/6/2024 08:43

28 June 2024

"A work group convened by the Alzheimer's Association has released revised biology-based criteria for the diagnosis and staging of Alzheimer's disease (AD), including a new biomarker classification system that incorporates fluid and imaging biomarkers as well as an updated disease staging system."



This is very significant for Proteome Sciences, as anyone who follows them closely will know that the biomarkers listed in this new 'biomarker classification system' are covered by PRM's patents. At their recent AGM Dr Ian Pike CSO told everyone that the p-tau 217 biomarker was only valid when used with 'other' biomarkers as described in Proteome Sciences patents. Well guess what, that's is exactly how the Alzheimer's Association has just defined their new protocol for AD disease in the link above.

All biomarkers listed in this new 'biomarker classification system' are covered in Proteome Sciences Alzheimer's disease patents.

[peverill] 26/6/2024 10:27

How much is Wasjobbers take out price,give or take a bit of dilution over the years I would be happy with £36 per share.Roll on the takeover I say.

[barry evans] 25/6/2024 09:07

I confess, I rather assumed he was referring to a joint administrator.

[monte1] 25/6/2024 09:00

‘Sooner’ - that term and PRM are exceedingly unlikely bedfellows.

[wasjobber] 25/6/2024 08:06

Joeblogg2,That's your choice, but in my opinion this is going to fly soon. PRM are in an excellent position and might be taken over sooner than many people think.

[barry evans] 25/6/2024 07:44

None whatsoever I should imagine, joeblogg2.

AIMHO, NAG.

[joeblogg2] 25/6/2024 07:39

Morning , I have like others suffered huge losses here but keep an eye on this. Any reason to get average down?

[canaletto] 25/6/2024 07:34

Respectfully, I think you will it is 20 years old Dominic

[dominiccummings] 23/6/2024 11:39

Could be soon. Mrs P's Kitchen must be looking shabby by now. It is near 15 years old isn't it?

[monte1] 22/6/2024 15:00

Great, it seems like we are all going to be fabulously wealthy then.
Any idea when, as a matter of interest?

tia

[pools2] 22/6/2024 08:32

TMTPro is the only way forward for large scale mass spec measurements.

[pools2] 22/6/2024 08:31

20th June 2024

Slavov said his lab also has a paper in press at Nature Protocols using multiplexing with 32-plex TMT reagents to analyze more than 1,000 single cells per day.

Kelly said that despite the challenges of multiplexed single-cell workflows, he believes they are "the only path forward to 1,000 cells per day," which means greater focus is needed on optimizing and streamlining these approaches to make running them feasible for a wider range of labs.

[goatherd] 19/6/2024 11:04

You may snear, but given that they have extremely limited funds, I can't think of a better way of carrying on.

If it comes to litigation I think they have adequate resources, or have friends who have.

[monte1] 19/6/2024 10:45

Further insight into latest PRM business plan;

Commercial In Confidence

‘Let’s just Wait and See’

Ends.

[elpirata] 19/6/2024 10:39

colin/pools

What is c/n capacity?



tia

[peverill] 19/6/2024 07:48

So a potless company worth a few million ££ is going to play hardball with a pharma worth £££££££,and demand millions is royalties.Get a grip Richard..

[barry evans] 19/6/2024 07:47

Some business model, that.

[goatherd] 19/6/2024 07:37

peverill,

You do not seem to understand PRM's tactics.

They have a large number of patents. They are simply watching other people testing and using them for reaearch (for which a license is not required). Then when (and if :-( )
they start to use them clinically, they will step in and demand royalties.

Of course they will not want to alert users too early, as the user might find different, non-PRM-patented, biomarkers; but if they wait until the user is heavily commited it should work.

[peverill] 19/6/2024 07:05

Is any of the Patent portfolio any good,Parkinson's test successful in early stage testing,I am taking it no biomarkers from PRM included,another opportunity missed.!!